Experimental Thrombosis on a Collagen Coated Arterioarterial Shunt in Rats: A Pharmacological Model to Study Antithrombotic Agents inhibiting Thrombin Formation and Platelet Deposition

Summary

A rat thrombosis model was developed to assess the efficacity of antithrombotic drugs. It had the following characteristics: controlled hemodynamic and rheological conditions corresponding to arterial flow, a collagen coated surface as a relevant thrombogenic stimulus, a method of measurement allowing dynamic monitoring of thrombus formation and the possibility to assess the thrombus structure. A shunt composed of polyethylene and silicone catheters, including in the middle of the shunt a collagen coated glass capillary, was inserted between the two primitive carotids of the rat. The duration of patency of the shunt was recorded using a thermic probe fixed on its central part. In this model, the patency of the shunt was 539 ± 55 s. Platelet and fibrinogen-fibrin accumulation in successive one centimeter segments along the shunt were measured using ¹¹¹In labeled platelets and ¹²⁵I labeled fibrinogen. Platelet accumulation occurred on the collagen coated surface and at the junctions between the different components of the shunt, where flow was disturbed. The effects of four antithrombotic agents were measured: aspirin, clopidogrel, heparin and r-hirudin. Clopidogrel, heparin and hirudin significantly prolonged patency duration of the shunt, whereas aspirin was inactive. Aspirin did not reduce platelet or fibrinogen-fibrin accumulation on the collagen coated surface. Platelet accumulation on the collagen surface was significantly lower in the clopidogrel group (50 mg/kg) than in the group treated with heparin (500 U/kg), demonstrating the direct antiplatelet effect of clopidogrel. Hirudin at doses giving similar values of APTT as heparin (500 U/kg) prolonged the occlusion time to over 2 h while the heparin occlusion time was only 20 min. We conclude that this experimental arterioarterial thrombosis model is sensitive to both antiplatelet and anticoagulant agents, allowing discrimination between antiplatelet and anticoagulant mechanisms of thrombosis prevention. The technique is easily performed in a small animal, fast and reproducible, and thus comparable to primate models for use in the screening of new antithrombotic drugs.

• References

• 1 Henry RL. Methods for inducing experimental thrombosis. Angiology 1962; 13: 554-577
• 2 Didisheim P. Animal models useful in the study of thrombosis and antithrombotic agents. Prog Hemostas Thromb 1972; 1: 165-196
• 3 Hladovec J. Experimental arterial thrombosis in rats with continuous registration. Thromb Diath Haemorrh 1971; 26: 407-410
• 4 Philp RB, Francey YI, Warren BA. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis. Haemostasis 1978; 7: 282-293
• 5 Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-280
• 6 Heras M, Chesebro JH, Penny WJ, Bailey KR, Badimon L, Fuster V. Effects of thrombin inhibition on the development of acute plateletthrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 1989; 3: 657-665
• 7 Lam JYT, Chesebro JH, Steele PM, Heras M, Webster MWI, Badimon L, Fuster V. Antithrombotic therapy for deep arterial injury by angioplasty – Efficacy of common platelet inhibition compared with thrombin inhibition in pigs. Circulation 1991; 84: 814-820
• 8 Lassila R, Badimon JJ, Vallabhajosula S, Badimon L. Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth. Arteriosclerosis 1990; 10: 306-315
• 9 Weiss HJ, Turitto VT, Vicic WJ, Baumgartner HR. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency. Blood 1984; 63: 1004-1014
• 10 Cadroy Y, Horbett TA, Hanson SR. Discrimination between platelet mediated and coagulation mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med 1989; 113: 436-448
• 11 Cazenave J-P, Blondowska D, Richardson M, Kinlough-Rathbone RL, Packham MA, Mustard JF. Quantitative radioisotopic measurement and scanning electron microscopic study of platelet adherence to a collagen coated surface and to subendothelium with a rotating probe device. J Lab Clin Med 1979; 93: 60-70
• 12 Mulvihill JN, Davies JA, Toti F, Freyssinet J-M, Cazenave J-P. Thrombin stimulated platelet accumulation on protein coated glass capillaries: role of adhesive platelet α-granule proteins. Thromb Haemostas 1989; 62: 989-995
• 13 Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988; 78: 1431-1442
• 14 Baker HJ, Lindsey JR, Weisbroth SH. (eds). The Laboratory Rat, Vol.1 and 2. New York: Academic Press; 1979
• 15 Gill III TJ, Smith GJ, Wissler RW, Kunz HW. The rat as an experimental animal. Science 1989; 245: 269-276
• 16 Smith LJ, Schaible KL, Fessler RG, Rachlin JR, Brown FD. Examination of the utility of the rat as an animal model for human anticoagulation. Haemostasis 1987; 17: 206-210
• 17 Maffrand JP, Bernat A, Delebassée D, Cazenave J-P, Gordon JL. ADP plays a key role in thrombogenesis in rats. Thromb Haemostas 1988; 59: 225-230
• 18 Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemostas 1986; 55: 415-435
• 19 Mulvihill JN, Huisman HG, Cazenave J-P, van Mourik JA, van Aken WG. The use of monoclonal antibodies to human platelet membrane glycoprotein IIb-IIIa to quantitate platelet deposition on artificial surfaces. Thromb Haemostas 1987; 58: 724-731
• 20 Eldrup-Jorgensen J, Connolly RJ, Mackey WC, Ramberg K, O'Donnell TF, Valeri R, Callow AD. Antiplatelet therapy and vascular grafts. Studies in a baboon ex vivo shunt. Arch Surgery 1986; 121: 778-781
• 21 Vogel GMT, Meuleman DG, Bourgondien FGM, Hobbelen PMJ. Comparison of two experimental thrombosis models in rats. Effects of four glycosaminoglycans. Thromb Res 1989; 54: 399-410
• 22 Hanson SR, Harker LA. Baboon models of acute arterial thrombosis. Thromb Haemostas 1987; 58: 801-805
• 23 Hornstra G, Vendelmans-Starrenburg A. Induction of experimental arterial occlusive thrombi in rats. Atherosclerosis 1973; 17: 369-382
• 24 Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis 1986; 6: 585-593
• 25 Molnar J, Lorand L. Studies on apyrases. Arch Biochem Biophys 1961; 93: 353-363
• 26 Ardlie NG, Packham MA, Mustard JF. Adenosine diphosphateinduced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol 1970; 19: 07-12
• 27 Gachet C, Stierlé A, Cazenave J-P, Ohlman P, Lanza F, Bouloux C, Maffrand J-P. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man. Biochem Pharmacol 1990; 40: 229-238
• 28 Eber M, Cazenave J-P, Grob JC, Abecassis J, Methlin G. ¹¹¹indium labelling of human washed platelets: kinetics and in vivo sequestration sites. In: Blood Cells in Nuclear Medicine. Part I. Cell Kinetics and Bio-distribution. Hardeman MR, Najean Y. (eds). Boston MA: Martinus Nijhoff Publishers; 1984: 29-43
• 29 Cazenave J-P, Hemmendinger S, Beretz A, Sutter-Bay A, Launay J. L’agrégation plaquettaire: outil d’investigation clinique et d’étude pharmacologique. Méthodologie. Ann Biol Clin 1983; 41: 167-179
• 30 Van Ruijven-Vermeer IAM, Nieuwenhuizen W. Purification of rat fibrinogen and its constituent chains. Biochem J 1978; 169: 653-658
• 31 Regoeczi E. Iodine-Labeled Plasma Proteins. CRC Press; Boca Raton, FL: 1984: 49-56
• 32 Freund M, Cazenave J-P, Courtney M, Degryse E, Roitsch C, Bernat A, Delebassée D, Defreyn G, Maffrand J-P. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats. Thromb Haemostas 1990; 63: 187-192
• 33 Wagner WR, Hubbel JA. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilisation on collagen in heparinized blood. J Lab Clin Med 1990; 116: 636-650
• 34 Chesebro JH, Zoldhelyi P, Badimon L, Fuster V. Role of thrombin in arterial thrombosis: implication for therapy. Thromb Haemostas 1991; 66: 01-05
• 35 Björk I, Olson ST, Shore JD. Molecular mechanisms of the accelerating effect of heparin on the relations between antithrombin and clotting proteinases. In: Heparin. Chemical and Biological Properties. Clinical Applications. Lane D, Lindahl U. (eds). Edward Arnold. 1989: 229-235
• 36 Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Haemostas 1991; 66: 141-152
• 37 Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Blood 1991; 2: 423-434
• 38 Kelly AB, Marzec UM, Krupski W, Bass A, Cadroy Y, Hanson S, Harker LA. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991; 77: 1006-1012
• 39 Butler KD, Ambler J, Dolan S, Giddings J, Talbot MD. A nonocclusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity. Blood Coagulat Fibrinol 1992; 3: 155-165
• 40 Hemker HC, Kessels H. Feedback mechanisms in coagulation. Haemostasis 1991; 21: 189-196
• 41 Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370
• 42 Chesebro JH, Fuster V. Dynamic thrombosis and thrombolysis. Role of antithrombins. Circulation 1991; 83: 1815-1817
• 43 Cadroy Y, Maraganore JM, Hanson SR, Harker LA. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons. Proc Natl Acad Sci 1991; 88: 1177-1181
• 44 Badimon L, Badimon JJ, Fuster V. Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches. Kardiologie 1990; 79: 133-145